InsidersTradesSigma
Track the 바이젠셀 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 바이젠셀 has published 2 insider filings. Market capitalisation: €106.8bn. The latest transaction was filed on 31 March 2026 (Sale). Among the most active insiders: 가은글로벌. The full history is free.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
바이젠셀 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in developing innovative solutions for disease treatment.